Genoscope


First Investment:
March 2026
Website:
Genoscope is a precision oncology diagnostics company developing Saliscope, a saliva-based companion diagnostic test for head and neck cancers that predicts therapeutic response and relapse risk.


First Investment:
March 2026
Website:
Genoscope is a precision oncology diagnostics company developing Saliscope, a saliva-based companion diagnostic test for head and neck cancers that predicts therapeutic response and relapse risk.